Cargando…

Development of a Bile Acid-Related Gene Signature for Predicting Survival in Patients with Hepatocellular Carcinoma

BACKGROUND: Hepatocellular carcinoma (HCC) is one of the most common diseases that threaten millions of lives annually. Evidence supports that bile acid (BA) affects HCC through inflammation, DNA damage, or other mechanisms. METHODS: A total of 127 BA-associated genes were analyzed in HCC tumor and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Gang, Guan, Jun, Yang, Qin, Wu, Fengtian, Shao, Junwei, Zhou, Qihui, Guo, Zixuan, Ren, Yanli, Zhu, Haihong, Chen, Zhi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9113879/ https://www.ncbi.nlm.nih.gov/pubmed/35592684 http://dx.doi.org/10.1155/2022/9076175

Ejemplares similares

Effect of ORF7 of SARS-CoV-2 on the Chemotaxis of Monocytes and Neutrophils In Vitro
por: Wang, Gang, et al.
Publicado: (2021)

A bile acid-related prognostic signature in hepatocellular carcinoma
por: Zhang, Wang, et al.
Publicado: (2022)

Bile acids as drivers and biomarkers of hepatocellular carcinoma
por: Colosimo, Santo, et al.
Publicado: (2022)

Identification of a bile acid and bile salt metabolism-related lncRNA signature for predicting prognosis and treatment response in hepatocellular carcinoma
por: Cui, Hao, et al.
Publicado: (2023)

Deregulated bile acids may drive hepatocellular carcinoma metastasis by inducing an immunosuppressive microenvironment
por: Xia, Jin-kun, et al.
Publicado: (2022)

Hepatocellular carcinoma: Novel understandings and therapeutic strategies based on bile acids (Review)
por: Luo, Wenyu, et al.
Publicado: (2022)

Immune signature-based hepatocellular carcinoma subtypes may provide novel insights into therapy and prognosis predictions
por: Zheng, Qiuxian, et al.
Publicado: (2021)

Abnormal bile acid-microbiota crosstalk promotes the development of hepatocellular carcinoma
por: Shen, Rui, et al.
Publicado: (2022)

A Prognostic Gene Signature for Hepatocellular Carcinoma
por: Chen, Rong, et al.
Publicado: (2022)

Gene signature to predict prognostic survival of hepatocellular carcinoma
por: Li, Li, et al.
Publicado: (2022)

Prognostic value of low skeletal muscle mass in hepatocellular carcinoma patients treated with sorafenib or lenvatinib: A meta-analysis
por: Guan, Jun, et al.
Publicado: (2021)

Emerging roles of bile acids in chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma
por: Xun, Zhen, et al.
Publicado: (2023)

Identification of the Pyroptosis-Related Gene Signature for Overall Survival Prediction in Patients With Hepatocellular Carcinoma
por: Liu, Shuang, et al.
Publicado: (2021)

Potential capacity of interferon-α to eliminate covalently closed circular DNA (cccDNA) in hepatocytes infected with hepatitis B virus
por: Wang, Gang, et al.
Publicado: (2021)

Interruption of bile acid enterohepatic circulation inhibits glycogen synthesis and promotes hepatocellular carcinoma progression
por: Wang, Jiyan, et al.
Publicado: (2023)

Effects of bile acids on hepatocellular signaling and secretion.
por: Beuers, U.
Publicado: (1997)

Imaging Features of Hepatocellular Carcinoma With Bile Duct Tumor Thrombus: A Multicenter Study
por: Wu, Jun-Yi, et al.
Publicado: (2021)

Role of bile acids in liver diseases mediated by the gut microbiome
por: Shao, Jun-Wei, et al.
Publicado: (2021)

Identification of an autophagy-related gene signature predicting overall survival for hepatocellular carcinoma
por: Xu, Wenfang, et al.
Publicado: (2021)

An Integrated Fibrosis Signature for Predicting Survival and Immunotherapy Efficacy of Patients With Hepatocellular Carcinoma
por: Liu, Long, et al.
Publicado: (2021)

Establishment and Validation of a Novel Risk Score for Hepatocellular Carcinoma Based on Bile Acid and Bile Salt Metabolism-Related Genes
por: Shi, Qingmiao, et al.
Publicado: (2023)

Concurrent bile duct resection versus concomitant thrombectomy for hepatocellular carcinoma associated with bile duct tumor thrombus: a propensity score matching analysis
por: Feng, Jin-Kai, et al.
Publicado: (2021)

Study on the gene signature related to immune microenvironment on viral and nonviral infections of hepatocellular carcinoma
por: Qian, Hong, et al.
Publicado: (2021)

Four-gene signature predicting overall survival and immune infiltration in hepatocellular carcinoma by bioinformatics analysis with RT‒qPCR validation
por: Guan, Renguo, et al.
Publicado: (2022)

N6-Methyladenine-Related Signature for Immune Microenvironment and Response to Immunotherapy in Hepatocellular Carcinoma
por: Ren, Shao-hua, et al.
Publicado: (2022)

Association of survival and genomic mutation signature with immunotherapy in patients with hepatocellular carcinoma
por: Ou, Qiyun, et al.
Publicado: (2020)

Tissue-infiltrating lymphocytes signature predicts survival in patients with early/intermediate stage hepatocellular carcinoma
por: Tian, Meng-Xin, et al.
Publicado: (2019)

Surgical treatment for hepatocellular carcinoma with bile duct invasion
por: Hu, Xu-guang, et al.
Publicado: (2016)

Model based on five tumour immune microenvironment-related genes for predicting hepatocellular carcinoma immunotherapy outcomes
por: Gu, Xinyu, et al.
Publicado: (2021)

An autophagy-related gene expression signature for survival prediction in multiple cohorts of hepatocellular carcinoma patients
por: Lin, Peng, et al.
Publicado: (2018)

Clinical Characteristics and Surgical Prognosis of Hepatocellular Carcinoma with Bile Duct Invasion
por: Meng, Ke-Wei, et al.
Publicado: (2014)

Identification of an Oxidative Stress-Related LncRNA Signature for Predicting Prognosis and Chemotherapy in Patients With Hepatocellular Carcinoma
por: Zhong, Zixuan, et al.
Publicado: (2022)

FXR induces SOCS3 and suppresses hepatocellular carcinoma
por: Guo, Fei, et al.
Publicado: (2015)

A novel five‐gene signature predicts overall survival of patients with hepatocellular carcinoma
por: Wang, Zhigang, et al.
Publicado: (2021)

Value of Bile Acids in Diagnosing Hepatitis C Virus-Induced Liver Cirrhosis and Hepatocellular Carcinoma
por: Khalil, Ashraf, et al.
Publicado: (2022)

Hepatocellular carcinoma with tumor thrombus in bile duct: A proposal of new classification according to resectability of primary lesion
por: Zhou, Di, et al.
Publicado: (2020)

Bile acid indices as biomarkers for liver diseases II: The bile acid score survival prognostic model
por: Alamoudi, Jawaher Abdullah, et al.
Publicado: (2021)

The Prediction of Survival in Hepatocellular Carcinoma Based on A Four Long Non-coding RNAs Expression Signature
por: Yang, Zongxing, et al.
Publicado: (2020)

A cancer stem cell associated gene signature for predicting overall survival of hepatocellular carcinoma
por: Liang, Xin-Yi, et al.
Publicado: (2022)

A novel DNA methylation‐driver gene signature for long‐term survival prediction of hepatitis‐positive hepatocellular carcinoma patients
por: Fu, Jie, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_i05qr2chrrbphtkr6ooa69ec8t